Eribulin in cutaneous breast cancer metastasis treatment: clinical activity and symptom control.

Aim: This observational study evaluated the behavior and outcome of cutaneous breast cancer metastasis treated with eribulin.

Patients & Methods: From November 2012 to January 2013, oncologists completed a database with patient, tumor and treatment characteristics from 14 Italian cancer centers. Skin lesions were assessed by Response Evaluation Criteria In Solid Tumors and cutaneous symptoms by present/absent criteria.

Assessment and treatment of symptoms among Italian medical oncologists.

Objectives: This work was conducted to evaluate symptoms assessment and use of patient-tailored protocols in clinical practice among Italian medical oncologists.

Methods: A questionnaire based on four topics (assessment of symptoms, assessment of a specific symptom, assessment of pain, use of patient-tailored protocols of treatment) was administered to 250 Italian medical oncologists.

Results: Of these oncologists, 43.